Gnirelin Acetate is an effective antagonist of the luteinizing hormone-releasing hormone receptor, which is used to control the stimulation of the ovaries and prevent premature release of immature follicles, thereby facilitating conception. It has played an important role in the treatment of various diseases such as prostate cancer and endometriosis.
Gonadorelin acetate is a synthetic decapeptide agonist of GnRH used in pharmaceutical synthesis. The core process involves solid-phase peptide synthesis followed by acetylation. Molecular Formula: C48H70N16O12; CAS No.: 58589-18-3.
Contraindicated in pregnancy and patients with hormone-sensitive tumors. Store at -20°C in a dry, dark environment to maintain stability. Handle with standard PPE to avoid inhalation or skin contact.